DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Bio Simulation Market: Trends Analysis & Forecasts to 2021" report to their offering.
The global Bio Simulation market is projected to reach USD 2.28 billion by the end of 2021, growing with a CAGR of 16.2% from 2016 to 2021
Biosimulation provides a systematic approach for integrating the clinical and biological data into functional metabolic pathways.
The applications of biosimulation include obtaining a quantitative understanding of regulation of blood levels and glucose simulated insulin secretion in order to investigate the role the various physiological processes play in diabetes and others. The areas of future research in biosimulation include obtaining a better understanding of disease heterogeneity and the biological changes that occur during disease progression to predict the effects of various therapeutic approaches on different categories of people.
The drug development application segment is further classified into preclinical testing and clinical trials. The drug discovery segment is divided into target identification & validation and lead identification & optimization. The end users for this market are academic and government research institutes, pharmaceutical and biotechnology companies, contract research organizations (CROs), regulatory authorities, and other end users (defense, nutraceuticals companies, and food and agricultural companies).
The companies covered in the report include
- Advanced Chemistry Development, Inc.
- Certara USA, Inc.
- Chemical Computing Group, Inc.
- Dassault Systèmes SA
- Entelos Holding Corporation
- Genedata Ag
- Physiomics PLC
- Rhenovia Pharma Ltd.
- Schrödinger Inc.
- Simulation Plus Inc.
Key Topics Covered:
1. Preface
2. Executive Summary
3. Global Bio Simulation Market Overview
4. Global Bio Simulation Market Analysis, by Product (USD Million, KT) 2014-2021
5. Global Bio Simulation Market Analysis, by Application (USD Million, KT) 2014-2021
6. Global Bio Simulation Market Analysis, by End User (USD Million, KT) 2014-2021
7. Global Bio Simulation Market Analysis, by Region (USD Million, KT) 2014-2021
8. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/lqzjlx/global_bio
Related Topics: Drug Discovery
